According to Zacks, Dentsply International (XRAY) is a better value stock compared to Merit Medical (MMSI) based on Zacks Rank and Style Scores. XRAY has a Zacks Rank of #2 (Buy) versus MMSI's #4 (Sell), a Value grade of A versus D, and lower valuation metrics including a forward P/E of 8.25 compared to 27.73, and a P/B ratio of 1.55 compared to 3.85, suggesting XRAY is currently undervalued relative to MMSI.
According to a Zacks analysis comparing Dentsply International (XRAY) and Merit Medical (MMSI) within the Medical - Dental Supplies sector, XRAY emerges as the more compelling value option. XRAY currently holds a Zacks Rank of #2 (Buy), indicative of positive earnings estimate revision trends and an improving analyst outlook, whereas MMSI is rated #4 (Sell). This fundamental strength is further supported by valuation metrics; XRAY exhibits a forward P/E ratio of 8.25, significantly lower than MMSI's 27.73. Additionally, XRAY's PEG ratio of 1.12 is more favorable than MMSI's 2.70, suggesting a better price relative to its earnings growth expectations. The Price-to-Book (P/B) ratio also favors XRAY at 1.55, compared to 3.85 for MMSI. Consequently, XRAY achieves a Value grade of A in Zacks' Style Scores system, while MMSI receives a D, reinforcing the assessment that XRAY presents a stronger value proposition for investors at this time.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.60
Ticker Sentiment